Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Impact of GLP-1 receptor agonists on cardiovascular outcomes in patients with peripheral artery disease without diabetes: A propensity score-matched analysis.
Emmanuel Daniel, Mohammed El-Nayir, Kayode Ogunniyi, Yash Patel, Paul Olayiwola, Omotola Oredipe, Henry Nwankwo, Karldon Nwaezeapu, Tioluwani Ojo
Published: 202510.1177/10815589251393978
Abstract
Peripheral artery disease (PAD) is associated with a high risk of cardiovascular events. While glucagon-like peptide-1 receptor agonists (GLP-1RAs) have demonstrated cardiovascular benefit in patients with diabetes, their role in patients with PAD wi…
Preview only. Read the full abstract at the source